6 Results for "

practice

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "practice" in MCE Product Catalog:

Cat. No.: HY-B1621A
CAS No.: 5870-29-1
Synonyms: DL-Cyclopentolate hydrochloride
Target:  

mAChR

Research Areas:  

Neurological Disease

Cyclopentolate (DL-Cyclopentolate) hydrochloride is an Atropine-like muscarinic receptors antagonist with a pKB value of 7.8 (on the circular ciliary muscle). Cyclopentolate hydrochloride is an anti-muscarinic agent commonly used in the ophthalmologic practice .
loading...
    loading...
Cat. No.: HY-B1621
CAS No.: 512-15-2
Synonyms: DL-Cyclopentolate
Target:  

mAChR

Research Areas:  

Neurological Disease

Cyclopentolate (DL-Cyclopentolate) is an Atropine-like muscarinic receptors antagonist with a pKB value of 7.8 (on the circular ciliary muscle). Cyclopentolate is an anti-muscarinic agent commonly used in the ophthalmologic practice .
loading...
    loading...
Cat. No.: HY-165190
CAS No.: 7775-50-0
Research Areas:  

Others

Tristearyl citrate is a triester of stearyl alcohol and citric acid that can function as a skin-conditioning agent-occlusive in cosmetic formulations, is assessed as safe in present practices of use and concentration in cosmetics, and is allowed as an indirect food additive.Tristearyl citrate can be used for the research of cosmetic formulation development .
loading...
    loading...
Cat. No.: HY-B1621AR
CAS No.: 5870-29-1
Synonyms: DL-Cyclopentolate hydrochloride (Standard)
Research Areas:  

Neurological Disease

Cyclopentolate (hydrochloride) (Standard) is the analytical standard of Cyclopentolate (hydrochloride). This product is intended for research and analytical applications. Cyclopentolate (DL-Cyclopentolate) hydrochloride is an Atropine-like muscarinic receptors antagonist with a pKB value of 7.8 (on the circular ciliary muscle). Cyclopentolate hydrochloride is an anti-muscarinic agent commonly used in the ophthalmologic practice .
loading...
    loading...
Cat. No.: HY-L261
169 compounds

MCE Classic FDA-Approved Drug Library features a curated selection of marketed drugs that have achieved the highest prescription volumes and greatest clinical impact in global practice since 2006. The collection covers eight major therapeutic areas, including cardiovascular diseases, oncology, metabolic disorders, infectious diseases, central nervous system disorders, respiratory diseases, digestive system diseases, and immunological conditions. All compounds have been validated through long‑term clinical use and possess well‑defined molecular targets, well‑established pharmacokinetic properties, quantifiable efficacy endpoints, and comprehensive toxicological safety profiles.

The library currently contains 169 representative drugs and is designed to serve as an efficient tool for drug repurposing, phenotypic screening, mechanism‑of‑action studies, and combination therapy strategy development.

Cat. No.: HY-L238
2,386 compounds

Mongolian medicine refers to drugs used for disease prevention and treatment under the guidance of Mongolian medical theory. Originating from the vast grasslands and desert regions of northern China, Mongolian medicine developed under specific natural conditions and a nomadic lifestyle, forming a unique theoretical system and treatment methods. It emphasizes the balance between the human body and the natural environment and has demonstrated distinct efficacy in treating digestive system diseases, rheumatism, skin diseases, and various chronic conditions. For example, Mongolian medicine often uses Chinese red date for palpitations and angina pectoris, sea buckthorn to relieve coughs, reduce phlegm, promote blood circulation, and remove blood stasis, and scabious to clear lung heat and treat liver heat diseases. The application of these characteristic Mongolian medicines embodies the profound wisdom of Mongolian medical practice.

With the advancement of modern technology, research on Mongolian medicine continues to deepen. Systematic studies on the chemical composition and pharmacological effects of Mongolian medicines can provide new ideas and methods for modern drug development.

MCE has collected 2,386 characteristic natural products derived from Mongolian medicines, with 400+ plant sources of Mongolian medicine.